Effectiveness of Lipid-Lowering Drug Guidelines in Heart Disease
Author Information
Author(s): Dalmau Rosa, Boira Miriam, Aguilar Carina, López Carlos, Rodríguez Dolors, Gentille Delicia, Bofill Domingo, Diogene Eduard, Pepió Josep M
Primary Institution: Institut Català de la Salut
Hypothesis
The implementation of lipid-lowering drug prescription guidelines will improve LDL cholesterol control in patients with ischaemic heart disease.
Conclusion
The study aims to improve the control of LDL cholesterol levels in patients with ischaemic heart disease through the implementation of clinical practice guidelines.
Supporting Evidence
- The study includes 3,402 patients with ischaemic heart disease.
- Training sessions for physicians are designed to improve drug prescription practices.
- The goal is to achieve LDL cholesterol levels below 100 mg/dl in patients.
Takeaway
Doctors are learning how to better prescribe cholesterol-lowering medications to help patients with heart disease feel better and live longer.
Methodology
A quasi-experimental uncontrolled before-and-after study involving training sessions for physicians and assessment of LDL cholesterol levels in patients.
Potential Biases
Potential bias due to the lack of randomization and the educational intervention reaching a maximum number of professionals.
Limitations
The study lacks a control group and randomization, which may affect the reliability of the results.
Participant Demographics
Patients with ischaemic heart disease from the Terres de l'Ebre region, including those newly diagnosed during the study period.
Statistical Information
P-Value
p<0.05
Confidence Interval
95%
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website